Profitability with Phototherapy: Targeted 308nm For Chronic Skin Diseases

Chronic skin conditions demand precision and practicality. When topicals plateau and systemic medications are a non-starter for localized disease, targeted 308 nm excimer therapy offers a powerful solution. Too many practices get stuck in legacy phototherapy programs with restrictive contracts, per-use charges, and clunky workflows that drain both your time and revenue. Exci308® changes the math, and the medicine.

Join Dr. Francisca Kartono as she reveals how Aerolase's Exci308 delivers real clinical results where other approaches fall short—with faster chair time per patient, streamlined protocols, and a practice-friendly economic model. We'll compare Exci308 with traditional narrowband UVB and legacy devices like XTRAC, highlighting exactly where those models add cost and integration barriers leading to lost opportunities.

Discussion Topics:

• Why Exci308 vs. Legacy Phototherapy: Compare restrictive per-treatment pricing and utilization commitments in devices like XTRAC versus Exci308's ownership model that delivers clinical flexibility and financial control.
• Clinical Precision, Less Time in Chair: Learn how targeted 308nm dosing accelerates clearance for Vitiligo, Psoriasis, and Atopic Dermatitis while faster setup and treatment times boost turnover and daily capacity.
• Patient Experience That Converts: Discover how pain-free, contactless treatments with minimal prep improve patient comfort, completion rates, and referral volume through real-world outcomes data.
• Economics That Actually Work: Explore reimbursement pathways, coding strategies, and workflow optimization that increase daily throughput and revenue without restrictive contracts or per-treatment fees.

‍

Register to watch this webinar live on October 30, 2025 at 8:00pm EST!

‍

Presented by Francisca Kartono, DO, FAOCD, FAAD

Board-certified dermatologist and the owner and medical director of MI Skin Center in Northville, MI. Dr. Kartono earned her Biochemistry degree from UCLA, attended Western University of Health Sciences for medical school, and completed her dermatology residency through Michigan State University. She has served as an assistant clinical professor at Ohio State University Medical Center and is currently faculty at multiple residency programs at Trinity Health and Beaumont Hospital System. Dr. Kartono has published extensively, lectured nationally, participated in clinical trials, and was recently appointed President of the American Osteopathic College of Dermatology.